Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase

被引:154
|
作者
Forouhar, Farhad
Anderson, J. L. Ross
Mowat, Christopher G.
Vorobiev, Sergey M.
Hussain, Arif
Abashidze, Mariam
Bruckmann, Chiara
Thackray, Sarah J.
Seetharaman, Jayaraman
Tucker, Todd
Xiao, Rong
Ma, Li-Chung
Zhao, Li
Acton, Thomas B.
Montelione, Gaetano T.
Chapman, Stephen K.
Tong, Liang [1 ]
机构
[1] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA
[2] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland
[3] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
[4] Rutgers State Univ, NE Struct Genom Consortium, Piscataway, NJ 08854 USA
关键词
cancer; heme enzymes; immunomodulation; indoleamine 2,3-dioxygenase;
D O I
10.1073/pnas.0610007104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO) constitute an important, yet relatively poorly understood, family of heme-containing enzymes. Here, we report extensive structural and biochemical studies of the Xanthomonas campestris TOO and a related protein SO4414 from Shewanella oneidensis, including the structure at 1.6-angstrom resolution of the catalytically active, ferrous form of TOO in a binary complex with the substrate L-Trp. The carboxylate and ammonium moieties of tryptophan are recognized by electrostatic and hydrogen-bonding interactions with the enzyme and a propionate group of the heme, thus defining the L-stereospecificity. A second, possibly allosteric, L-Trp-binding site is present at the tetramer interface. The sixth coordination site of the heme-iron is vacant, providing a dioxygen-binding site that would also involve interactions with the ammonium moiety Of L-Trp and the amide nitrogen of a glycine residue. The indole ring is positioned correctly for oxygenation at the C2 and C3 atoms. The active site is fully formed only in the binary complex, and biochemical experiments confirm this induced-fit behavior of the enzyme. The active site is completely devoid of water during catalysis, which is supported by our electrochemical studies showing significant stabilization of the enzyme upon substrate binding.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 50 条
  • [41] Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated
    Charehjoo, Arian
    Majidpoor, Jamal
    Mortezaee, Keywan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 118
  • [42] Serum Indoleamine 2,3-Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis
    Suzuki, Yuzo
    Suda, Takafumi
    Asada, Kazuhiro
    Miwa, Seiichi
    Suzuki, Masako
    Fujie, Michio
    Furuhashi, Kazuki
    Nakamura, Yutaro
    Inui, Naoki
    Shirai, Toshihiro
    Hayakawa, Hiroshi
    Nakamura, Hirotoshi
    Chida, Kingo
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (03) : 436 - 442
  • [43] Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas
    Liu, Jinzhong
    Lu, Gaofeng
    Tang, Fuai
    Liu, Yiqing
    Cui, Guanglin
    VIRCHOWS ARCHIV, 2009, 455 (05) : 441 - 448
  • [44] Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation
    Carvalho, Catarina
    Siegel, David
    Inman, Martyn
    Xiong, Rui
    Ross, David
    Moody, Christopher J.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, 12 (17) : 2663 - 2674
  • [45] Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds
    Di Pucchio, Tiziana
    Danese, Silvio
    De Cristofaro, Raimondo
    Rutella, Sergio
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (02) : 229 - 250
  • [46] Aminophenoxazinones as Inhibitors of Indoleamine 2,3-Dioxygenase (IDO). Synthesis of Exfoliazone and Chandrananimycin A
    Pasceri, Raffaele
    Siegel, David
    Ross, David
    Moody, Christopher J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (08) : 3310 - 3317
  • [47] Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells
    Ozawa, Yoshinari
    Yamamuro, Shun
    Sano, Emiko
    Tatsuoka, Juri
    Hanashima, Yuya
    Yoshimura, Sodai
    Sumi, Koichiro
    Hara, Hiroyuki
    Nakayama, Tomohiro
    Suzuki, Yutaka
    Yoshino, Atsuo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 524 (03) : 723 - 729
  • [48] Indoleamine 2,3-Dioxygenase Activity and Expression in Patients With Chronic Lymphocytic Leukemia
    Lindstrom, Vesa
    Aittoniemi, Janne
    Jylhava, Juulia
    Eklund, Carita
    Hurme, Mikko
    Paavonen, Timo
    Oja, Simo S.
    Itala-Remes, Maija
    Sinisalo, Marjatta
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (05) : 363 - 365
  • [49] Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses
    Kollgaard, Tania
    Klausen, Tobias Wirenfeldt
    Idorn, Manja
    Holmgaard, Rikke Baek
    Straten, Per Thor
    Andersen, Mads Hald
    ONCOIMMUNOLOGY, 2012, 1 (04): : 441 - 447
  • [50] Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators
    Sorensen, Rikke Baek
    Hadrup, Sine Reker
    Svane, Inge Marie
    Hjortso, Mads Christian
    Straten, Per Thor
    Andersen, Mads Hald
    BLOOD, 2011, 117 (07) : 2200 - 2210